09 May 2023
11 May 2023
Rs. 3200 Cr
19 May 2023
₹ 95 to ₹ 100 per share
Nexus Select Trust is India's leading real estate investment trust. Nexus Select Trust is India's leading consumption centre platform with 17 Grade-A best-in-class Urban Consumption Centres spread across 14 cities. The company owns 17 Grade A urban consumption centres with a total Leasable Area of 9.8 msf, two complementary hotel assets (354 keys), and three office assets of 1.3 msf as of December 31, 2022.
Objective of the Nexus Select Trust IPO: The company intends to utilize the net proceeds from the issue towards the funding of the following objects: 1. Partial or full repayment or prepayment and redemption of certain financial indebtedness of the Asset SPVs and the Investment Entity; 2. Acquisition of stake and redemption of debt securities in certain Asset SPVs; and 3. General purposes.
The minimum lot size and investment required for the Nexus Select Trust IPO is 150 shares.
The IPO comprise of a fresh issue of equity shares aggregating to ₹1400 crores.
The allotment date of Mankind Pharma IPO is set for 3rd May.
Book running lead managers to the issue are: 1. Bofa Securities India Limited 2. Axis Capital Limited 3. Citigroup Global Markets India Private Limited 4. Hsbc Securities & Capital Markets Pvt Ltd 5. IIFL Securities Ltd 6. Jm Financial Limited 7. J.P. Morgan India Private Limited 8. Kotak Mahindra Capital Company Limited 9. Morgan Stanley India Company Pvt Ltd 10. Sbi Capital Markets Limited